The differences in CD8 and CD4 antigens towards tumor antigens NY-ESO-1, Melan-A, MAGE-A3 and survivin in context of melanoma treatment was reported by Graham Pawelec (Pawelec, 2025). The gene discussed is CD8A; the disease is neoplasm.